We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.32B
AUM Growth
+$241M
Cap. Flow
+$64.7M
Cap. Flow %
2.79%
Top 10 Hldgs %
43.21%
Holding
64
New
9
Increased
30
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$66.8M
2
CLDX icon
Celldex Therapeutics
CLDX
+$33M
3
KERX
Keryx Biopharmaceuticals Inc
KERX
+$32.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$29M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$27.8M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$58.3M
2
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$55.4M
3
GILD icon
Gilead Sciences
GILD
+$52.6M
4
MDVN
MEDIVATION, INC.
MDVN
+$37.8M
5
VPHM
VIROPHARMA INC
VPHM
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 89.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KERX
26
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$35.7M 1.54%
+2,758,950
New +$32.9M
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$28.5M 1.23%
472,400
+46,200
+11% +$2.51M
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$25.8M 1.11%
1,001,814
+35,028
+4% +$851K
INSM icon
29
Insmed
INSM
$22.7B
$25.4M 1.09%
1,492,121
+45,300
+3% +$694K
BSX icon
30
Boston Scientific
BSX
$67.6B
$25.3M 1.09%
2,101,605
+616,533
+42% +$7.28M
ISRG icon
31
Intuitive Surgical
ISRG
$128B
$25.2M 1.09%
+591,525
New +$24.9M
ABBV icon
32
AbbVie
ABBV
$454B
$25M 1.08%
+472,672
New +$23.2M
MDVN
33
DELISTED
MEDIVATION, INC.
MDVN
$24.8M 1.07%
777,520
-1,249,538
-62% -$37.8M
COV
34
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$24.7M 1.06%
362,479
+22,667
+7% +$1.47M
TEVA icon
35
Teva Pharmaceuticals
TEVA
$36.2B
$24.6M 1.06%
613,649
+179,600
+41% +$7.07M
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$23.7M 1.02%
454,364
+201,600
+80% +$9.61M
ILMN icon
37
Illumina
ILMN
$28.7B
$23.3M 1%
216,588
-143,612
-40% -$13.2M
AKRX
38
DELISTED
Akorn Inc
AKRX
$21.9M 0.94%
887,482
+150,400
+20% +$3.4M
UTHR icon
39
United Therapeutics
UTHR
$26.3B
$20.6M 0.89%
+182,000
New +$16.4M
ALGN icon
40
Align Technology
ALGN
$12B
$18.3M 0.79%
321,047
-50,391
-14% -$2.71M
PCYC
41
DELISTED
PHARMACYCLICS INC
PCYC
$17.8M 0.77%
168,425
– –
RDY icon
42
Dr. Reddy's Laboratories
RDY
$9.8B
$17.8M 0.77%
2,170,950
-40,750
-2% -$323K
SGNT
43
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$17.5M 0.75%
689,729
+125,404
+22% +$2.83M
SGEN
44
DELISTED
Seagen Inc. Common Stock
SGEN
$16.9M 0.73%
422,519
-100
-0% -$4.08K
MNTA
45
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$15.8M 0.68%
894,696
+42,600
+5% +$716K
HTWR
46
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$15.6M 0.67%
165,675
+58,324
+54% +$4.93M
TRNX
47
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$10.8M 0.46%
573,321
+141,801
+33% +$2.67M
ARAY icon
48
Accuray
ARAY
$26.8M
$7.55M 0.33%
868,386
-67,966
-7% -$527K
NXTM
49
DELISTED
NxStage Medical Inc.
NXTM
$7.53M 0.32%
753,434
-347,566
-32% -$3.94M
DXCM icon
50
DexCom
DXCM
$28.3B
$5.67M 0.24%
640,868
-137,764
-18% -$1.09M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Sectoral Asset Management held 64 positions worth $2.32B, up 12% from $2.08B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Sectoral Asset Management's Q4 2013 filing shows 9 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Keryx Biopharmaceuticals Inc: 2,758,950 shares worth $35.7M. The largest sale was Incyte, an estimated $58.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 86% a quarter earlier.

  • Sectoral Asset Management's largest Q4 2013 buy was Keryx Biopharmaceuticals Inc: 2,758,950 shares worth $35.7M.
  • Sectoral Asset Management added most to Biogen in Q4 2013, an estimated $66.8M increase.
  • Sectoral Asset Management's biggest Q4 2013 reduction was Incyte, cutting an estimated $58.3M.
  • Sectoral Asset Management fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $55.4M.
  • Sectoral Asset Management's ten largest holdings make up 43% of its $2.32B portfolio in Q4 2013.
  • Sectoral Asset Management opened 9 new positions and closed 5 in Q4 2013.
  • Sectoral Asset Management's portfolio value rose 12% quarter-over-quarter to $2.32B.

Based on Sectoral Asset Management's 13F filing for Q4 2013, filed 12 Feb 2014.